Sierra Ventures Raises $265 Million Fund XIII, Exceeding Target
Sierra Ventures Raises $265 Million Fund XIII, Exceeding Target
Source: pr-inside.com
📰 Ralph Passarella News
Ralph Passarella News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ralph Passarella. Real-time updates on events, politics, business and more.
OneStudyTeam, Antidote partner to aid in clinical trial workflow
The partnership will offer one platform for clinical trial sponsors, sites and participants.
Source: mobihealthnews.com
Reify Health Raises $220M in Series D Funding; Valued at $4.8 Billion
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
United States Ralph Passarella Dragoneer Investment Group Reify Health Altimeter Capital Adams Street
Source: finsmes.com
Clinical trial tech company Reify Health scores $220M, bumping valuation to $4.8B
Reify said it will use the investment to focus its tools on increased diversity in clinical trials.
Source: mobihealthnews.com
Reify Health Secures $220M to Support Clinical Trial Diversity
Reify Health, a provider of solutions that empower the clinical trial ecosystem raises $220M to support clinical trial diversity...
Ralph Passarella Reify Health Secures Dragoneer Investment Group Reify Health Support Clinical Trial Should Know
Source: hitconsultant.net
Reify Health launches tool to gauge clinical trial diversity
The StudyTeam Diversity Reporting feature is intended to aid sites and sponsors measure their efforts to reach patients from underrepresented communities.
Ralph Passarella Reify Health Studyteam Diversity Patient Centricity Clinical Development Linical Evolution
Source: outsourcing-pharma.com
AstraZeneca taps Reify tech to boost breast cancer trials
The pharma firm plans to use the StudyTeam platform to accelerate development, ease site burdens and improve patient matching for breast cancer studies. Reify Health has announced pharmaceutical firm AstraZeneca has opted to use the StudyTeam patient enrollment platform to help accelerate clinical development along its breast cancer pipeline. Reify CEO and cofounder Ralph Passarella spoke with Outsourcing-Pharma about the partnership, and how his company’s cloud-ba...
Source: outsourcing-pharma.com